{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:00:18Z","timestamp":1787497218370,"version":"build-2736575974"},"reference-count":43,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To determine if systemic corticosteroid therapy is associated with improved outcomes for children hospitalized with community-acquired pneumonia (CAP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>In this multicenter, retrospective cohort study we used data from 36 children's hospitals for children aged 1 to 18 years with CAP. Main outcome measures were length of stay (LOS), readmission, and total hospitalization cost. The primary exposure was the use of adjunct systemic corticosteroids. Multivariable regression models and propensity scores were used to adjust for confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>The 20 703 patients whose data were included had a median age of 4 years. Adjunct corticosteroid therapy was administered to 7234 patients (35%). The median LOS was 3 days, and 245 patients (1.2%) required readmission. Systemic corticosteroid therapy was associated with shorter LOS overall (adjusted hazard ratio [HR]: 1.24 [95% confidence interval (CI): 1.18\u20131.30]). Among children who received treatment with \u03b2-agonists, the LOS was shorter for children who had received corticosteroids compared with children who had not (adjusted HR: 1.36 [95% CI: 1.28\u20131.45]). Among children who did not receive \u03b2-agonists, the LOS was longer for those who received corticosteroids compared with those who did not (adjusted HR: 0.85 [95% CI: 0.75\u20130.96]). Corticosteroids were associated with readmission of patients who did not receive concomitant \u03b2-agonist therapy (adjusted odds ratio: 1.97 [95% CI: 1.09\u20133.57]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>For children hospitalized with CAP, adjunct corticosteroids were associated with a shorter hospital LOS among patients who received concomitant \u03b2-agonist therapy. Among patients who did not receive this therapy, systemic corticosteroids were associated with a longer LOS and a greater odds of readmission. If \u03b2-agonist therapy is considered a proxy for wheezing, our findings suggest that among patients admitted to the hospital with a diagnosis of CAP, only those with acute wheezing benefit from adjunct systemic corticosteroid therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1542\/peds.2010-0983","type":"journal-article","created":{"date-parts":[[2011,1,10]],"date-time":"2011-01-10T22:07:48Z","timestamp":1294697268000},"page":"e255-e263","source":"Crossref","is-referenced-by-count":48,"title":["Adjunct Corticosteroids in Children Hospitalized With Community-Acquired Pneumonia"],"prefix":"10.1542","volume":"127","author":[{"given":"Anna K.","family":"Weiss","sequence":"first","affiliation":[{"name":"Divisions of General Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hall","sequence":"additional","affiliation":[{"name":"Child Health Corporation of America, Shawnee Mission, Kansas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace E.","family":"Lee","sequence":"additional","affiliation":[{"name":"Divisions of General Pediatrics and"},{"name":"Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Kronman","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania;"},{"name":"Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Sheffler-Collins","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir S.","family":"Shah","sequence":"additional","affiliation":[{"name":"Divisions of General Pediatrics and"},{"name":"Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania;"},{"name":"Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania"},{"name":"Departments of Biostatistics and Epidemiology and"},{"name":"Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2011,2,1]]},"reference":[{"issue":"4","key":"2021121007102065100_B1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.inf.0000157250.95880.91","article-title":"Lower respiratory tract infections among American Indian and Alaska Native children and the general population of U.S. Children","volume":"24","author":"Peck","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"2021121007102065100_B2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archpedi.162.7.675","article-title":"Primary early thoracoscopy and reduction in length of hospital stay and additional procedures among children with complicated pneumonia: results of a multicenter retrospective cohort study","volume":"162","author":"Shah","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"2021121007102065100_B3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1086\/338460","article-title":"An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations","volume":"34","author":"Byington","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"9568","key":"2021121007102065100_B4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"2021121007102065100_B5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMra074111","article-title":"Acute lower respiratory tract infection","volume":"358","author":"Mizgerd","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"2021121007102065100_B6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00023.2002","article-title":"Unique structural features that influence neutrophil emigration into the lung","volume":"83","author":"Burns","year":"2003","journal-title":"Physiol Rev"},{"issue":"2","key":"2021121007102065100_B7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000084039","article-title":"Inflammation: a new therapeutic target in pneumonia","volume":"72","author":"Cazzola","year":"2005","journal-title":"Respiration"},{"issue":"2","key":"2021121007102065100_B8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1164\/ajrccm\/141.2.471","article-title":"Macrophages and polymorphonuclear neutrophils in lung defense and injury","volume":"141","author":"Sibille","year":"1990","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"2021121007102065100_B9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/infdis\/159.2.189","article-title":"Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response","volume":"159","author":"Nelson","year":"1989","journal-title":"J Infect Dis"},{"issue":"11","key":"2021121007102065100_B10","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1164\/rccm.200506-888OC","article-title":"Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia","volume":"172","author":"Yende","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2021121007102065100_B11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1183\/09031936.00154107","article-title":"Corticosteroids in severe pneumonia","volume":"32","author":"Sibila","year":"2008","journal-title":"Eur Respir J"},{"issue":"7","key":"2021121007102065100_B12","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/ajrccm.165.7.2106014","article-title":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids","volume":"165","author":"Meduri","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2021121007102065100_B13","first-page":"CD004405","article-title":"Corticosteroids for acute bacterial meningitis","author":"van de Beek","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2021121007102065100_B14","first-page":"CD006150","article-title":"Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection","author":"Briel","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2021121007102065100_B15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1034\/j.1399-3003.1999.14a37.x","article-title":"Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study","volume":"14","author":"Mont\u00f3n","year":"1999","journal-title":"Eur Respir J"},{"issue":"5","key":"2021121007102065100_B16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00408-007-9020-3","article-title":"Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization","volume":"185","author":"Mikami","year":"2007","journal-title":"Lung"},{"issue":"5","key":"2021121007102065100_B17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1183\/09031936.00027607","article-title":"Effects of systemic steroids in patients with severe community-acquired pneumonia","volume":"30","author":"Garcia-Vidal","year":"2007","journal-title":"Eur Respir J"},{"issue":"3","key":"2021121007102065100_B18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study","volume":"171","author":"Confalonieri","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"2021121007102065100_B19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.200905-0808OC","article-title":"Efficacy of corticosteroids in community-acquired pneumonia: a randomized double blinded clinical trial","volume":"181","author":"Snijders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2021121007102065100_B20","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/cc6922","article-title":"The role of corticosteroids in severe community-acquired pneumonia: a systematic review","volume":"12","author":"Salluh","year":"2008","journal-title":"Crit Care"},{"issue":"3","key":"2021121007102065100_B21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ppul.20374","article-title":"Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children","volume":"41","author":"Lee","year":"2006","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"2021121007102065100_B22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jinf.2008.06.012","article-title":"Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children","volume":"57","author":"Tamura","year":"2008","journal-title":"J Infect"},{"issue":"17","key":"2021121007102065100_B23","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1001\/jama.299.17.2048","article-title":"Corticosteroids and mortality in children with bacterial meningitis","volume":"299","author":"Mongelluzzo","year":"2008","journal-title":"JAMA"},{"issue":"9","key":"2021121007102065100_B24","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/606048","article-title":"Intravenous immunoglobulin in children with streptococcal toxic shock syndrome","volume":"49","author":"Shah","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2021121007102065100_B25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/0885713X9701200404","article-title":"Community-acquired pneumonia: can it be defined with claims data?","volume":"12","author":"Whittle","year":"1997","journal-title":"Am J Med Qual"},{"issue":"6","key":"2021121007102065100_B26","doi-asserted-by":"crossref","DOI":"10.1542\/peds.107.6.e99","article-title":"Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services","volume":"107","author":"Feudtner","year":"2001","journal-title":"Pediatrics"},{"issue":"1","key":"2021121007102065100_B27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"5","key":"2021121007102065100_B28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jclinepi.2005.07.004","article-title":"A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods","volume":"59","author":"St\u00fcrmer","year":"2006","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2021121007102065100_B29","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/pds.969","article-title":"Principles for modeling propensity scores in medical research: a systematic literature review","volume":"13","author":"Weitzen","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2021121007102065100_B30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1162\/003465304323023651","article-title":"Nonparametric estimation of average treatment effects under heterogeneity: a review","volume":"86","author":"Imbens","year":"2004","journal-title":"Rev Econ Stat"},{"key":"2021121007102065100_B31","first-page":"446","article-title":"Introduction to regression modeling","volume-title":"Modern Epidemiology","author":"Greenland","year":"2008","edition":"3rd ed."},{"issue":"8","key":"2021121007102065100_B32","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/AAC.48.8.2787-2792.2004","article-title":"Hazard ratio in clinical trials","volume":"48","author":"Spruance","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"2021121007102065100_B33","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ppul.20633","article-title":"Systemic cytokine profile in children with community-acquired pneumonia","volume":"42","author":"Michelow","year":"2007","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"2021121007102065100_B34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1034\/j.1399-3038.2002.01093.x","article-title":"Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy","volume":"13","author":"Gern","year":"2002","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"2021121007102065100_B35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2222.1997.tb00666.x","article-title":"Bronchial hyperresponsiveness and cytokines in virus-induced asthma exacerbations","volume":"27","author":"Johnston","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"2021121007102065100_B36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1099-0496(1999)27:18+<141::AID-PPUL47>3.0.CO;2-A","article-title":"The role of viral and atypical bacterial pathogens in asthma pathogenesis","volume":"18","author":"Johnston","year":"1999","journal-title":"Pediatr Pulmonol Suppl"},{"issue":"2","key":"2021121007102065100_B37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1096-9071(199902)57:2<186::AID-JMV17>3.0.CO;2-Q","article-title":"Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice","volume":"57","author":"Peebles","year":"1999","journal-title":"J Med Virol"},{"issue":"5","key":"2021121007102065100_B38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1165\/ajrcmb.24.5.4315","article-title":"Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model","volume":"24","author":"Martin","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"2021121007102065100_B39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1542\/peds.113.4.701","article-title":"Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children","volume":"113","author":"Michelow","year":"2004","journal-title":"Pediatrics"},{"issue":"10","key":"2021121007102065100_B40","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/392498","article-title":"Mycoplasma pneumoniae and asthma in children","volume":"38","author":"Biscardi","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2021121007102065100_B41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"issue":"8","key":"2021121007102065100_B42","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/591915","article-title":"The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection","volume":"198","author":"Tagliabue","year":"2008","journal-title":"J Infect Dis"},{"issue":"6","key":"2021121007102065100_B43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/382050","article-title":"Inhaled fluticasone propionate reduces concentration of Mycoplasma pneumoniae, inflammation, and bronchial hyperresponsiveness in lungs of mice","volume":"189","author":"Chu","year":"2004","journal-title":"J Infect Dis"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/127\/2\/e255\/1054883\/zpe0021100e255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/127\/2\/e255\/1054883\/zpe0021100e255.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T11:54:02Z","timestamp":1639137242000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/127\/2\/e255\/65240\/Adjunct-Corticosteroids-in-Children-Hospitalized"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,1]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2,1]]},"published-print":{"date-parts":[[2011,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2010-0983","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,1]]}}}